HCW Biologics Insider Purchases:
HCW Biologics CEO Hing C. Wong acquires 113,879 common shares worth $160,499
HCW Biologics director Scott T. Garrett reports purchase of 177,936 shares for $249,501.12
HCW Biologics CFO Rebecca Byam acquires 14,235 shares for $19,998.68
Keep an eye for a pop tomorrow